[Post-marketing surveillance of a drug with anti-sclerotic activity. Preliminary results].
D001161:Arteriosclerosis / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D010204:Pantetheine / Q000009:adverse effects / Q000627:therapeutic use*; D011358:Product Surveillance, Postmarketing; D013438:Sulfhydryl Compounds / Q000627:therapeutic use*
D013438:Sulfhydryl Compounds; D010204:Pantetheine
"Post-marketing surveillance" (PMS) di un farmaco ad attività anti-aterosclerotica. Risultati preliminari.